Since the coronavirus that causes COVID-19 started spreading rapidly in early 2020, it has illustrated the global devastation that pandemics can inflict and the critical need for more robust public health preparedness.
The global Methicillin-Resistant Staphylococcus Aureus (MRSA) Treatment Market reached US$ 3.57 Bn in 2022 (up by 4.7% over 2021). Outbreak of Covid-19 in the short-term, backed by “innovation” in the long run, is expected to drive the market.Sepsis, toxic shock syndrome, bacteremia, osteomyelitis, endocarditis, men.